Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • A leading biotech company is seen as a strong buy due to minimal impact from potential pricing changes and expected solid earnings growth.
  • A data centre operator has secured significant new contracts, leading analysts to view its shares as undervalued despite some EBITDA concerns.
  • Improving residential sentiment and supportive industry factors drive positive outlooks for a major property company's sales volumes.

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

CSL Ltd (ASX: CSL)

According to a note out of UBS, its analysts have retained their buy rating and $300.00 price target on this biotechnology company's shares. The broker has been looking at the impact that Most Favored Nation (MFN) pricing could have on CSL. It estimates that only around 10% of CSL's US sales are exposed to MFN, which would have a modest impact on its future earnings compared to the worst-case scenario. In addition, it sees limited consumer demand impacts from MFN pricing. And there is a chance that the company could receive full exemption depending on its investments in facilities in the US market. As a result, the broker remains positive and continues to forecast solid earnings growth from CSL in the coming years. The CSL share price is trading at $204.71 on Monday afternoon.

DigiCo Infrastructure REIT (ASX: DGT)

Another note out of UBS reveals that its analysts have retained their buy rating and $4.90 price target on this data centre operator's shares. This follows news that Digico has secured new customer wins from a combination of Hyperscale, Neocloud, Enterprise and Government customers. These contracts will increase Digico's Australian contracted IT capacity to 41MW by June 2026, which is 57% higher than its previous 2026 target of 26MW. UBS estimates that this suggests that the company is on target to achieve consensus earnings estimates for FY 2027. And while it does have concerns about its EBITDA per MW potentially being lower than expected, UBS remains positive and sees its shares as undervalued at current levels. The DigiCo share price is fetching $2.91 at the time of writing.

Stockland Corporation Ltd (ASX: SGP)

Analysts at Morgan Stanley have retained their overweight rating and $6.90 price target on this property company's shares. According to the note, the broker's research indicates that residential sentiment is improving. It believes this is a positive for Stockland and should be supportive of growing sales volumes. This is particularly the case given how house prices are expected to continue increasing and the new First Home Guarantee is likely to be supportive of the industry. The Stockland share price is trading at $6.22 on Monday.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Macquarie says this Gina Rinehart-backed miner could pile on more than 150% in value

A big jump in rare earths resources has the analysts interested.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Broker Notes

Data centre work could help drive this ASX industrial stock to a record high

This company has a track record of strong growth.

Read more »

A view of competitors in a running event, some wearing number bibs, line up together on a starting line looking ahead as if to start a race.
Broker Notes

Buy, hold, sell: Sonic Healthcare, AMP, CBA shares

Let's start the week with some fresh ratings from the experts. 

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Group of people toasting with wine
Broker Notes

Buy, hold, sell: Transurban, Orora, Treasury Wine Estates shares

Here's what top broker Morgans thinks of these 3 ASX 200 shares following their FY26 reports.

Read more »

Businessman studying a high technology holographic stock market chart.
Broker Notes

8 ASX 200 shares with fresh buy ratings this week

Brokers retained a positive view on Westpac, Sonic Healthcare, Minerals 260, and other shares.

Read more »

Woman working on her laptop at a café.
Broker Notes

7 ASX 200 shares downgraded by the experts this week

Brokers reduced their ratings on IAG, Seek, Woolworths, and other ASX 200 stocks.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans names 3 ASX shares to buy

The broker has good things to say about these shares. Here's what you need to know.

Read more »